We could not find any results for:
Make sure your spelling is correct or try broadening your search.
BURLINGTON, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches for the treatment...
Received IDE approval for the Revita® Remain-1 pivotal study for weight maintenance in patients with obesity after discontinuation of GLP-1 Based Drugs Completion of enrollment in pivotal...
Revita aims to be the first approved therapeutic option for durable weight maintenance after discontinuation of GLP-1 based drugs, as an adjunct to diet and exercise With this FDA IDE approval...
Data provides first demonstration of glucose lowering and weight loss potency from pancreas-produced native human GLP-1, highlighting the capacity of pancreatic GLP-1 to provide metabolic control...
Data provides first demonstration of glucose lowering and weight loss potency from pancreas-produced native human GLP-1, highlighting the capacity of pancreatic GLP-1 to provide metabolic control...
LEXINGTON, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (“Fractyl Health” or the “Company”), a metabolic therapeutics company focused on pioneering new approaches...
LEXINGTON, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Fractyl Health (Nasdaq: GUTS), a metabolic therapeutics company focused on pioneering new approaches for the treatment of type 2 diabetes...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.17 | 2.60336906585 | 6.53 | 6.88 | 6.02 | 142573 | 6.51281075 | CS |
4 | 0.91 | 15.7167530225 | 5.79 | 7.84 | 5.75 | 250453 | 7.09352405 | CS |
12 | -7.05 | -51.2727272727 | 13.75 | 14.5 | 5.75 | 375391 | 8.38496879 | CS |
26 | -7.05 | -51.2727272727 | 13.75 | 14.5 | 5.75 | 375391 | 8.38496879 | CS |
52 | -7.05 | -51.2727272727 | 13.75 | 14.5 | 5.75 | 375391 | 8.38496879 | CS |
156 | -7.05 | -51.2727272727 | 13.75 | 14.5 | 5.75 | 375391 | 8.38496879 | CS |
260 | -7.05 | -51.2727272727 | 13.75 | 14.5 | 5.75 | 375391 | 8.38496879 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions